Patent application number | Description | Published |
20080210396 | Measurement System for Improved Paper Roll Runnability - A system for measuring both caliper and tension of a web such as paper wound into a roll. The system may include a standard caliper sensor whose air supply is selectively modified to allow for both the measurement of caliper and tension of the web. In another embodiment two similar or identical measurement devices are installed in tandem where one device measures tension without pinching the sheet and the other device measures caliper. The sensor may include two sheet guides for providing support for tension measurement or one or both sheet guides can be eliminated by support from machinery rolls. | 09-04-2008 |
20090056156 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
20090059232 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
20090059244 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
20090088889 | Accurate Tracking Of Web Features Through Converting Processes - There is described a method and apparatus for tracking the location of web features through a converting process, one application of which can involve tracking paper defects from a paper machine as detected by a camera system, to a winder where the sheet is wound to rolls so that the web defects can be repaired in the winder before making the rolls. The method to track web features is based on pattern identification of inherent sheet variability or defects. The apparatus involves two or more sheet property or defect monitoring web sensors arranged at the same cross directional location at different stages of the converting operation, augmented by tachometers and/or roll diameter sensors. A full automation system for drive control on the winder based on this information is preferably added to make maximum advantage of this information. | 04-02-2009 |
20090168749 | Synchronized Wireless Networked System - A sheet making system that has two or more separated nodes one of which may be a scanner sensing head and the other of which may be a scanner end column. Each node has a wireless system and receives power from a common AC source. Each node receives events data associated with the wireless system. Each wireless system has a circuit that obtains from the common AC power source an associated events data acquisition clock that is the same for all of the wireless systems to time synchronize to each other the associated events data signals at each of the two or more nodes. A central computer may be connected to the two or more nodes. The communication between the computer and each of the two or more nodes can be wireless or by a LAN or other mechanisms. | 07-02-2009 |
Patent application number | Description | Published |
20140007886 | SURGICAL DRAPE SYSTEM FOR UROLOGY PROCEDURES ON MALE PATIENTS - A simple surgical drape system of generally flat shape for male urology procedures that provides full isolation of top versus bottom surface by a sealing fenestration surrounding the meatus area. It is achieved by manually forming the flat drape to a tent-like shape around the penis with a fenestration aperture smaller than glans diameter, supported by and sealing to the glans tip, and then attaching a penile clamp to hold the drape. This allows a simplified safer antibacterial preparation and less chance of infection complications. The sealed design permits better management of urology liquids, and can use absorption pad on drape top side. The drape wrinkles act as a penile position stabilizer, reducing need for extended use of the one operator hand for penile support. Drape is removable with catheter in place. | 01-09-2014 |
20140107496 | SENSING CATHETER EMITTING RADIANT ENERGY - A sensing catheter having an outer flexible sheath and a proximal section containing a sensing system having a sensing means, a radiant energy providing means and radiation transmitting means, preferably all housed within a fluid channel. | 04-17-2014 |
20140235942 | MEDICAL DEVICE AND METHOD FOR INTERNAL HEALING AND ANTIMICROBIAL PURPOSES - Process and device for directly medicinally treating interior tissue during or after intubation of a patient by passing medicinal radiant energy transversely through the intubation device to irradiate the internal patient tissue for promoting healing or for an antimicrobial effect. The invention is useful in conjunction with endoscopies and catherizations, such as urinary catherization, gastric and pulmonary endoscopies, and the like procedures. The process and device can also provide liquid flow and/or vision. | 08-21-2014 |
20140303447 | SURGICAL DRAPE SYSTEM FOR UROLOGY PROCEDURES ON FEMALE PATIENTS - The invention is a simple surgical drape system for female urology procedures that provides sealed isolation of top versus bottom sides of the drape and only exposes the female urethral meatus area for the procedure. It is achieved by a combination of a drape with a fenestration, a labia spreader where the drape fenestration is attached to provide a seal, and local illumination of the meatus area integrated in the drape system for safer and easier instrument insertion. The labia spreader also frees up one of the operator's hands and provides protection for false catherization. The labia spreader can have a vaginal inserted portion for precise position fixation of the drape fenestration to the female. The drape system also provides improved liquid management made possible by the unique combination of drape and labia spreader acting as seal between the two sides of the drape. | 10-09-2014 |
Patent application number | Description | Published |
20130073173 | DYNAMIC ESTIMATOR FOR DETERMINING OPERATING CONDITIONS IN AN INTERNAL COMBUSTION ENGINE - Methods and systems are provided for estimating engine performance information for a combustion cycle of an internal combustion engine. Estimated performance information for a previous combustion cycle is retrieved from memory. The estimated performance information includes an estimated value of at least one engine performance variable. Actuator settings applied to engine actuators are also received. The performance information for the current combustion cycle is then estimated based, at least in part, on the estimated performance information for the previous combustion cycle and the actuator settings applied during the previous combustion cycle. The estimated performance information for the current combustion cycle is then stored to the memory to be used in estimating performance information for a subsequent combustion cycle. | 03-21-2013 |
20130073185 | PREDICTIVE MODELING AND REDUCING CYCLIC VARIABILITY IN AUTOIGNITION ENGINES - Methods and systems are provided for controlling a vehicle engine to reduce cycle-to-cycle combustion variation. A predictive model is applied to predict cycle-to-cycle combustion behaviour of an engine based on observed engine performance variables. Conditions are identified, based on the predicted cycle-to-cycle combustion behaviour, that indicate high cycle-to-cycle combustion variation. Corrective measures are then applied to prevent the predicted high cycle-to-cycle combustion variation. | 03-21-2013 |
20130090837 | FUEL GOVERNOR FOR CONTROLLED AUTOIGNITION ENGINES - Methods and systems for controlling combustion performance of an engine are provided. A desired fuel quantity for a first combustion cycle is determined. One or more engine actuator settings are identified that would be required during a subsequent combustion cycle to cause the engine to approach a target combustion phasing. If the identified actuator settings are within a defined acceptable operating range, the desired fuel quantity is injected during the first combustion cycle. If not, an attenuated fuel quantity is determined and the attenuated fuel quantity is injected during the first combustion cycle. | 04-11-2013 |
20130090838 | FUELING STRATEGY FOR CONTROLLED-AUTOIGNITION ENGINES - Methods and systems for controlling combustion performance of an engine during recompression HCCI combustion are provided. The method includes regulating a valve actuation timing and a fuel injection timing to cause a combustion phasing of at least one cylinder of the engine to approach a target combustion phasing, and estimating current combustion state information based on the combustion phasing. The current combustion state information includes at least one of a temperature, a pressure, and a pre-combustion charge composition associated with the at least one cylinder. The method further includes determining a target fuel injection amount, and determining whether the target fuel injection amount would require actuator settings that violate predetermined constraints in order to cause the combustion phasing to approach the target combustion phasing. A fuel injection amount is adjusted when the target fuel injection amount would require actuator settings that violate the predetermined constraints. | 04-11-2013 |
20140230780 | REAL-TIME RESIDUAL MASS ESTIMATION WITH ADAPTIVE SCALING - Systems and methods are described for on-line, real-time estimation of a residual mass in an engine cylinder during HCCI combustion. The residual mass is estimated based on an estimated residual mass for a previous combustion cycle. A value of a first performance variable for the first combustion cycle is determined based only on engine data measured by one or more sensors. A value of a second performance is estimated based at least in part on the estimated residual mass for the first combustion cycle. An adaptive scaling factor is determining for the first combustion cycle based on the determined value of the first performance variable and the estimated value of the second performance variable. An adjusted residual mass for the first combustion cycle is then determined based on the estimated residual mass for the first combustion cycle and the adaptive scaling factor for the first combustion cycle. | 08-21-2014 |
20140283800 | MIXED-MODE COMBUSTION CONTROL - Methods and systems are described for controlling engine combustion during a mixed-mode combustion modality. A target exhaust valve timing is determined based on a first combination of engine speed and load. An amount of trapped residual in an engine cylinder after an exhaust valve is closed during a first combustion cycle is also determined. Based at least in part on the amount of trapped residual, an amount of gas that will be drawn into the engine cylinder when the intake valve is opened during a second combustion cycle is determined. The target exhaust valve timing is then adjusted during the second combustion cycle in order to adjust the amount of gas that will be drawn into the engine cylinder when the intake valve is opened during a third combustion cycle. | 09-25-2014 |
Patent application number | Description | Published |
20090042224 | METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER - In one embodiment, methods are provided for assessing the presence of mesothelin-expressing tumor cells in a human subject. In another embodiment, methods are provided for monitoring the efficacy of treatment of a human cancer patient diagnosed with a mesothelin-expressing tumor. | 02-12-2009 |
20090104684 | Diagnosis of carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 04-23-2009 |
20100047818 | DIAGNOSIS OF CARCINOMAS - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 02-25-2010 |
20110104675 | Methods and Compositions for Diagnosing Carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble forms of mesothelin polypeptides, including mesothelin related antigen (MRA). In particular the invention provides a nucleic acid sequence encoding MRA and an MRA variant. The invention also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a mesothelin polypeptide with a molecule naturally occurring in soluble form in a sample from such a subject, and by hybridization screening using an MRA nucleotide sequence, as well as other related advantages. | 05-05-2011 |
20110300186 | Functionalized Nano- and Micro-materials for Medical Therapies - Compositions containing an optionally surface-functionalized mesoporous support and a biologically active agent, and pharmaceutical compositions of the same, are provided herein. Such compositions can be useful in the treatment of tumors, for example, by injection of the composition at a location near the site of the tumor. | 12-08-2011 |
20130224772 | METHOD FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS - The present invention features, inter alia, compositions and methods related to the detection of HE4-expressing tumor cells in a subject. The methods include detection of anti-HE4 antibodies in a biological sample obtained from the subject. The methods are useful for diagnosis and monitoring the efficacy of treatments for cancers in which HE4 is expressed, for example, ovarian cancer. | 08-29-2013 |
Patent application number | Description | Published |
20090042224 | METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER - In one embodiment, methods are provided for assessing the presence of mesothelin-expressing tumor cells in a human subject. In another embodiment, methods are provided for monitoring the efficacy of treatment of a human cancer patient diagnosed with a mesothelin-expressing tumor. | 02-12-2009 |
20090104684 | Diagnosis of carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 04-23-2009 |
20110104675 | Methods and Compositions for Diagnosing Carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble forms of mesothelin polypeptides, including mesothelin related antigen (MRA). In particular the invention provides a nucleic acid sequence encoding MRA and an MRA variant. The invention also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a mesothelin polypeptide with a molecule naturally occurring in soluble form in a sample from such a subject, and by hybridization screening using an MRA nucleotide sequence, as well as other related advantages. | 05-05-2011 |
20110300186 | Functionalized Nano- and Micro-materials for Medical Therapies - Compositions containing an optionally surface-functionalized mesoporous support and a biologically active agent, and pharmaceutical compositions of the same, are provided herein. Such compositions can be useful in the treatment of tumors, for example, by injection of the composition at a location near the site of the tumor. | 12-08-2011 |
20130224772 | METHOD FOR DETECTING ANTI-HE4 ANTIBODIES AND METHODS OF DIAGNOSIS AND/OR PROGNOSIS OF CONDITIONS ASSOCIATED WITH HE4-EXPRESSING CELLS - The present invention features, inter alia, compositions and methods related to the detection of HE4-expressing tumor cells in a subject. The methods include detection of anti-HE4 antibodies in a biological sample obtained from the subject. The methods are useful for diagnosis and monitoring the efficacy of treatments for cancers in which HE4 is expressed, for example, ovarian cancer. | 08-29-2013 |
Patent application number | Description | Published |
20110248401 | NANOTUBE-BASED ELECTRODES - Transparent electrodes are manufactured. In accordance with various example embodiments, a transparent electrode is manufactured by generating a solution including a composite material having nanotubes and a conjugated polymer, in which the nanotubes constitute a majority of the composite material by weight. The conjugated polymer is used to disperse the nanotubes in the solution, and the solution is coated onto a substrate to form an electrode including a network of the carbon nanotubes. | 10-13-2011 |
20130330559 | DOPING OF CARBON-BASED STRUCTURES FOR ELECTRODES - Various aspects of the present disclosure are directed toward carbon-based electrodes. The carbon-based electrodes include a composition of carbon-based structures treated with an oxide material. The composition is annealed, including application of heat in excess of 200 degrees Celsius, which causes the reduction of the oxide material by electron transfer from the carbon-based structures. Additionally, the annealing facilitates stabilization and conductivity of the electrode. | 12-12-2013 |
20140109695 | NANOSTRUCTURES WITH STRAIN-INDUCED RESISTANCE - Apparatuses and methods, consistent with embodiments herein, are directed to an apparatus having a stretchable substrate and a plurality of nanostructures. While the plurality of nanostructures are adhered to the stretchable substrate, the stretchable substrate and the nanostructures are stretched and/or operate in a stretched mode in which the nanostructures are characterized by a resistance corresponding to a strain imparted due to the stretching. When the substrate is relaxed or the stretching otherwise lessened, the nanostructures continue to be characterized as a function of the strain and the corresponding resistance, with buckled segments of the nanostructures being adhered along a surface of the substrate. | 04-24-2014 |